Treace Medical Concepts Inc (TMCI) PT Lowered to $8 at JPMorgan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts TMCI Hot Sheet
Price: $4.28 --0%
Rating Summary:
2 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 11 | New: 7
Rating Summary:
2 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 11 | New: 7
Join SI Premium – FREE
JPMorgan analyst Lilia-Celine B Lozada lowered the price target on Treace Medical Concepts Inc (NASDAQ: TMCI) to $8.00 (from $9.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Beta Technologies (BETA) PT Lowered to $28 at Needham
- People Incorporated (PPLI) PT Lowered to $47 at Citizens - Shares Meaningfully Undervalue Business
- Duolingo Inc. (DUOL) PT Raised to $165 at Needham
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
